[Debates surrounding COPD]

Rev Mal Respir. 2010 Feb;27(2):106-7. doi: 10.1016/j.rmr.2010.01.013.
[Article in French]
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Editorial

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Albuterol / adverse effects
  • Albuterol / analogs & derivatives
  • Albuterol / therapeutic use
  • Androstadienes / adverse effects
  • Androstadienes / therapeutic use
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Breathing Exercises
  • Bronchodilator Agents / adverse effects
  • Bronchodilator Agents / therapeutic use*
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Fluticasone
  • Humans
  • Oxygen Inhalation Therapy
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / mortality
  • Randomized Controlled Trials as Topic
  • Salmeterol Xinafoate
  • Scopolamine Derivatives / adverse effects
  • Scopolamine Derivatives / therapeutic use
  • Smoking Cessation
  • Tiotropium Bromide

Substances

  • Adrenal Cortex Hormones
  • Androstadienes
  • Anti-Inflammatory Agents
  • Bronchodilator Agents
  • Scopolamine Derivatives
  • Salmeterol Xinafoate
  • Fluticasone
  • Albuterol
  • Tiotropium Bromide